# Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer

> **NCT04941872** · NA · COMPLETED · sponsor: **The First Affiliated Hospital of Xiamen University** · enrollment: 7 (actual)

## Conditions studied

- Tumor, Solid, FAPI, PET/CT, Metastasis

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT

## Key facts

- **NCT ID:** NCT04941872
- **Lead sponsor:** The First Affiliated Hospital of Xiamen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-18
- **Primary completion:** 2022-06-24
- **Final completion:** 2022-11-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941872, "Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04941872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*